Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Cabenuva: The Complete Long-acting Injectable Antiretroviral Regimen

Date: Jul 27, 2021 12:00 PM - 01:00 PM



CE Hours


CE Units


Registration closes on Sep 20, 2021 10:00 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists
  • Healthcare Professionals


Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Joint Provider(s)

Clinical Pharmacy Associates (CPA)



Registration Closed  


  • Describe the history of antiretroviral (ARV) therapy.
  • List the indications and dosing of Cabenuva (Cabotegravir extended-release injectable suspension; rilpivirine extended-release injectable suspension for intramuscular injection, CTG ERIS; RPV ERIS)
  • Recall the Cabenuva clinical trials of safety and efficacy
  • Describe the Cabenuva dispensing process
  • List potential future indications for Cabenuva


Hope Coleman, PharmD, BCPS, AAHIVP, PharmD, BCPS
Senior Associate, Clincial Pharmacy Associates, Inc

Activity Number

Date: 07/27/21
Time: 12:00 PM - 01:00 PM

CE Hours

Registration Closed